Identification of a Tuberculosis Cluster through Epidemiological and Geographical Tracing of a Patient with Multidrug-resistant Tuberculosis in Lopburi Province, Thailand, 2014
DOI:
https://doi.org/10.59096/osir.v10i2.263148Keywords:
tuberculosis, multidrug-resistant, contact tracing, quality of care, ThailandAbstract
In May 2014, a suspected multidrug-resistant tuberculosis (MDR-TB) outbreak in Lopburi Province was investigated following the national guidelines for tuberculosis (TB) outbreak investigation and assessed the quality of patient care based on the International Standards for TB Care. The case finding focused on TB cases diagnosed during December 2012 to August 2014. Medical charts were reviewed at Khok Samrong Hospital and contacts of a MDR-TB case who was lost to follow up were traced back. Study findings found an epidemiologically linked cluster of TB cases with five geographically related cases and four cases were from the same family. Factors that might have contributed to this TB outbreak were identified as well, including delay in diagnosis and sub-standard care, low socioeconomic status, delay in conducting contact tracing, and an ineffective TB database system. Diagnosis, treatment and prevention activities should be improved to prevent further TB outbreaks in the communities.
References
Thailand. Bureau of Tuberculosis, Department of Disease Control. Ministry of Public Health. National tuberculosis control programme guidelines, 2013. 2nd ed. Bangkok: The War Veterans Organization of Thailand under Royal Patronage of His Majesty the King; 2013. Thai.
World Health Organization. Global tuberculosis report 2015. Geneva: World Health organization; 2015 [cited 2016 Sep 1]. <http://www.who.int/tb/publications/global_report/gtbr15_main_text.pdf>
Caminero JA, editor. Guidelines for clinical and operational management of drug-resistant tuberculosis. Paris: International Union against Tuberculosis and Lung Disease; 2013 [cited 2016 Sep 1]. <http://www.theunion.org/what-we-do/publications/technical/english/mdr-tbguide_6-19-13_web.pdf>
Reechaipichitkul W, editor. Guideline for programmatic management of drug-resistant tuberculosis. Bangkok: The Agricultural Cooperative Federation of Thailand Ltd; 2013.p.1-6. Thai [cited 2016 Sep 1]. <http://www.tbnfmthailand.org/Download/DR-TB%20Proof%2023%20FINAL.pdf>
Oeltmann JE, Varma JK, Ortega L, Liu Y, O’Rourke T, Cano M, et al. Multidrug-resistant tuberculosis outbreak among US-bound Hmong Refugees, Thailand, 2005. Emerg Infect Dis. 2008;14(11):1715-21.
Jiraphonsa C, Wangteeraprasert T, Henpaserttae N, Sanguanwongse N, Panya L, Sukkasitvanichkul J, et al. Community outbreak of multidrug resistance tuberculosis, Kanchanaburi Province, Thailand on 2002-June 2010. Journal of Preventive Medicine Association of Thailand. 2011;1(3):261-71. Thai [cited 2016 Sep 1]. <http://thailand.digitaljournals.org/index.php/JOMAT/article/view/12756>
Thailand. Bureau of Tuberculosis. Department of Disease Control. Ministry of Public Health. Guideline of TB outbreak investigation. 2nd ed. Bangkok: The War Veterans Organization of Thailand under Royal Patronage of His Majesty the King; 2013. Thai [cited 2016 Sep 1]. <http://www.tbthailand.org/document.php?id=67>
World Health Organization. Guidelines on the management of latent tuberculosis infection. Spain: WHO Press; 2015 [cited 2016 Sep 1]. <http://www.who.int/tb/publications/latent-tuberculosis-infection/en/>
World Health Organization. Automated real-time nucleic acid and amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for diagnosis of pulmonary and extra-pulmonary TB in adults and children. Geneva: World Health Organization; 2013 [cited 2016 Sep 1]. <http://apps.who.int/iris/bitstream/10665/112472/1/9789241506335_eng.pdf>
Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med.2010;363:1005-15.
Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet. 2011 Apr 30;377(9776):1495-505. Epub 2011 Apr 18.
Vattanaviboon P, Sukchawalit R, Jearanaikoon P, Chuchottaworn C, Ponglikitmongkol M. Analysis of RNA polymerase gene mutation in three isolates of rifampicin resistant Mycobacterium tuberculosis. Southeast Asian J Trop Med Public Health. 1995;26 Suppl 1:333-6.
Hillemann D, Rusch-Gerdes S, Richter E. Evaluation of the GenoType MTBDRplus Assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol. 2007;45:2635-4015.
TB CARE I. International Standards for Tuberculosis Care. 3rd ed. The Hague: TB CARE I; 2014 [cited 2016 Sep 1]. <http://www.who.int/tb/publications/ISTC_3rdEd.pdf>
Lönnroth K, Williams BG, Stadlin S, Jaramillo E, Dye C. Alcohol use as a risk factor for tuberculosis–a systematic review. BMC Public Health. 2008 Aug 14;8:289.
World Health Organization. TB fact sheets 2016 [cited 2016 Dec 30]. <http://www.who.int/mediacentre/factsheets/fs104/en/>
Grandjean L, Gilman RH, Martin L, Soto E, Castro B, Lopez S, et al. Transmission of multidrug-resistant and drug-susceptible tuberculosis within households: a prospective cohort study. PLOS Medicine. 2015;12(6): e1001843.
Cohen T, Murray M. Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nature Medicine. 2004;10(10):1117-21.
Centers for Disease Control and Prevention. Guidelines for the investigation of contacts of persons with infectious tuberculosis; recommendations from the National Tuberculosis Controllers Association and CDC. MMWR. 2005;54(RR15):1-37.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Outbreak, Surveillance, Investigation & Response (OSIR) Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
